Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer

BERWYN, Pa., Aug. 29, 2022 /PRNewswire/ -- Annovis Bio, Inc. , a clinical-stage drug platform company addressing neurodegenerative diseases, announced the appointment of Henry Hagopian III as Chief... | August 29, 2022

Related Keywords

Berwyn ,Pennsylvania ,United States ,Marial Maccecchini ,Nic Johnson ,Annovis Bio ,Jeff Mcgroarty ,Exchange Commission ,Prnewswire Annovis Bio Inc ,Linkedin ,Twitter ,Annovis Bio Inc ,Russo Partners ,Henry Hagopian ,Chief Financial Officer ,Senior Vice President ,Chief Financial ,Carroll Graduate School ,Boston College ,Silberman College ,Farleigh Dickinson ,Annual Report ,Investor Contact ,Nc Stock Exchange ,News ,Information ,Press Release ,022 ,Annovis ,Drug ,Platform ,Company ,Ddressing ,Neurodegenerative ,Nnounced ,The ,Appointment ,F ,Henry ,Agopian ,Wii ,As Anvs Us03615a1088 ,